David Thomas - Publications

Affiliations: 
National Institute for Dental and Craniofacial Research, Bethesda, MD, United States 
Area:
pain

79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Antar AAR, Yu T, Pisanic N, Azamfirei R, Tornheim JA, Brown DM, Kruczynski K, Hardick JP, Sewell T, Jang M, Church T, Walch SN, Reuland C, Bachu VS, Littlefield K, ... ... Thomas DL, et al. Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients. Medrxiv : the Preprint Server For Health Sciences. PMID 33688688 DOI: 10.1101/2021.03.02.21252420  0.36
2021 Sugawara S, El-Diwany R, Cohen LK, Rousseau KE, Williams CYK, Veenhuis RT, Mehta SH, Blankson JN, Thomas DL, Cox AL, Balagopal A. People with HIV-1 demonstrate type 1 interferon refractoriness associated with upregulated USP18. Journal of Virology. PMID 33658340 DOI: 10.1128/JVI.01777-20  0.36
2020 Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, ... ... Thomas DL, et al. Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection. Genes and Immunity. PMID 33230236 DOI: 10.1038/s41435-020-00119-z  0.36
2020 Falade-Nwulia O, Hackman J, Mehta SH, McCormick SD, Kirk GD, Sulkowski M, Thomas D, Latkin C, Laeyendecker O, Ray SC. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore. Bmc Infectious Diseases. 20: 815. PMID 33167892 DOI: 10.1186/s12879-020-05546-x  0.36
2020 Vergara C, Valencia A, Thio CL, Goedert JJ, Mangia A, Piazzolla V, Johnson E, Kral AH, O'Brien TR, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, ... ... Thomas DL, et al. A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus. The Journal of Infectious Diseases. PMID 33119750 DOI: 10.1093/infdis/jiaa677  0.36
2020 Vergara C, Duggal P, Thio CL, Valencia A, Brien TRO, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, ... ... Thomas DL, et al. Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection. Genes and Immunity. PMID 33116245 DOI: 10.1038/s41435-020-00115-3  0.36
2020 Falade-Nwulia O, Gicquelais RE, Astemborski J, McCormick SD, Kirk G, Sulkowski M, Thomas DL, Mehta SH. Hepatitis C Treatment Uptake among People who Inject Drugs in the Oral Direct-Acting Antiviral Era. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32770638 DOI: 10.1111/liv.14634  0.36
2020 Irvin R, Ntiri-Reid B, Kleinman M, Agee T, Hitt J, Anaedozie O, Arowolo T, Cassidy-Stewart H, Bush C, Wilson LE, Millman AJ, Nelson NP, Canary L, Brinkley S, Moon J, ... ... Thomas DL, et al. Sharing the Cure: Building Primary Care and Public Health Infrastructure to Improve the Hepatitis C Care Continuum in Maryland. Journal of Viral Hepatitis. PMID 32671942 DOI: 10.1111/jvh.13360  0.36
2020 Boon D, Bruce V, Patel EU, Quinn J, Srikrishnan AK, Shanmugam S, Iqbal S, Balakrishnan P, Sievers M, Kirk GD, Thomas DL, Quinn TC, Cox AL, Page KA, Solomon SS, et al. Antibody avidity-based approach to estimate population-level incidence of hepatitis C. Journal of Hepatology. PMID 32240715 DOI: 10.1016/j.jhep.2020.03.028  0.36
2020 Falade-Nwulia O, Sacamano P, McCormick SD, Yang C, Kirk G, Thomas D, Sulkowski M, Latkin C, Mehta SH. Individual and network factors associated with HCV treatment uptake among people who inject drugs. The International Journal On Drug Policy. 78: 102714. PMID 32135398 DOI: 10.1016/j.drugpo.2020.102714  0.36
2020 Falade-Nwulia O, Ward KM, McCormick S, Mehta SH, Pitts SR, Katz S, Chander G, Thomas DL, Sulkowski M, Latkin CA. Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care. Journal of Viral Hepatitis. PMID 32045086 DOI: 10.1111/jvh.13274  0.36
2020 Clipman SJ, Duggal P, Srikrishnan AK, Saravanan S, Balakrishnan P, Vasudevan CK, Celentano DD, Thomas DL, Mehta SH, Solomon SS. Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission. The Journal of Infectious Diseases. PMID 31917837 DOI: 10.1093/infdis/jiaa006  0.36
2019 Irvin R, Chander G, Ward KM, Manogue S, Falade-Nwulia O, Moon J, Sutcliffe CG, Brinkley S, Haselhuhn T, Katz S, Herne K, Arteaga L, Thomas DL, Mehta SH, Sulkowski MS. Unreported Alcohol Use Was Common But Did Not Impact Hepatitis C Cure in HIV-Infected Persons Who Use Drugs. Journal of Viral Hepatitis. PMID 31854069 DOI: 10.1111/jvh.13251  0.36
2019 Hackman J, Falade-Nwulia O, Patel EU, Mehta SH, Kirk GD, Astemborski J, Ray SC, Thomas DL, Laeyendecker O. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 104078. PMID 31669367 DOI: 10.1016/j.meegid.2019.104078  0.36
2019 Falade-Nwulia O, Sutcliffe CG, Mehta SH, Moon J, Chander G, Keruly J, Katzianer J, Thomas DL, Moore RD, Sulkowski MS. Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum. Open Forum Infectious Diseases. 6: ofz426. PMID 31667200 DOI: 10.1093/ofid/ofz426  0.36
2019 Suhas Solomon S, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Singh Sachdeva K, et al. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial. Journal of Hepatology. PMID 31604081 DOI: 10.1016/j.jhep.2019.09.022  0.36
2019 Islam S, Piggott DA, Moriggia A, Astemborski J, Mehta SH, Thomas DL, Kirk GD. Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users. Harm Reduction Journal. 16: 38. PMID 31208419 DOI: 10.1186/s12954-019-0312-8  0.36
2019 Patel EU, Mehta SH, Boon D, Quinn TC, Thomas DL, Tobian AAR. Reply to MacDonald et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31125394 DOI: 10.1093/cid/ciz441  0.36
2019 Irvin R, Chander G, Falade-Nwulia O, Astemborski J, Starbird L, Kirk GD, Sulkowski MS, Thomas DL, Mehta SH. Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs. Addictive Behaviors. 96: 56-61. PMID 31035079 DOI: 10.1016/j.addbeh.2019.04.023  0.36
2019 Falade-Nwulia O, Irvin R, Merkow A, Sulkowski M, Niculescu A, Olsen Y, Stoller K, Thomas DL, Latkin C, Mehta SH. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore. Journal of Substance Abuse Treatment. 100: 45-51. PMID 30898327 DOI: 10.1016/j.jsat.2019.01.021  0.36
2019 Cepeda JA, Astemborski J, Kirk GD, Celentano DD, Thomas DL, Mehta SH. Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland. Plos One. 14: e0213357. PMID 30830944 DOI: 10.1371/journal.pone.0213357  0.36
2018 Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, ... ... Thomas DL, et al. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology. PMID 30593799 DOI: 10.1053/j.gastro.2018.12.014  0.36
2018 Patel EU, Mehta SH, Boon D, Quinn TC, Thomas DL, Tobian AAR. Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239645 DOI: 10.1093/cid/ciy803  0.36
2018 Patel EU, Solomon SS, Mcfall AM, Srikrishnan AK, Pradeep A, Nandagopal P, Laeyendecker O, Tobian AAR, Thomas DL, Sulkowski MS, Kumar MS, Mehta SH. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India. The International Journal On Drug Policy. 57: 51-60. PMID 29679811 DOI: 10.1016/j.drugpo.2018.03.023  0.36
2018 Irvin R, McAdams-Mahmoud A, White J, Grant Z, Falade-Nwulia O, Sherman S, Beyrer C, Sulkowski M, Thomas DL, Mehta SH, Chaisson R. An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus. Progress in Community Health Partnerships : Research, Education, and Action. 12: 101-109. PMID 29606698 DOI: 10.1353/cpr.2018.0011  0.36
2017 Solomon SS, Sulkowski MS, Amrose P, Srikrishnan AK, McFall AM, Ramasamy B, Kumar MS, Anand S, Thomas DL, Mehta SH. Directly Observed Therapy of Sofosbuvir/Ribavirin +/- Peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). Journal of Viral Hepatitis. PMID 28719029 DOI: 10.1111/jvh.12761  0.36
2017 Falade-Nwulia O, Sutcliffe C, Moon J, Chander G, Wansom T, Keruly J, Katzianer J, Nathanson A, Marks J, Mehta S, Thomas D, Moore R, Sulkowski M. High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center. Hepatology (Baltimore, Md.). PMID 28608973 DOI: 10.1002/hep.29308  0.36
2017 Kandathil AJ, Breitwieser FP, Sachithanandham J, Robinson M, Mehta SH, Timp W, Salzberg SL, Thomas DL, Balagopal A. Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs. Annals of Internal Medicine. PMID 28586923 DOI: 10.7326/M17-0085  0.36
2017 Lazo M, Nwankwo C, Daya NR, Thomas DL, Mehta SH, Juraschek S, Willis K, Selvin E. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 28579183 DOI: 10.1016/j.cgh.2017.04.046  0.36
2017 Quinn J, Astemborski J, Mehta SH, Kirk GD, Thomas DL, Balagopal A. HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline. Pathogens & Immunity. 2: 50-59. PMID 28503671 DOI: 10.20411/pai.v2i1.183  0.36
2017 Wansom T, Falade-Nwulia O, Sutcliffe CG, Mehta SH, Moore RD, Thomas DL, Sulkowski MS. Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era. Open Forum Infectious Diseases. 4: ofx024. PMID 28480293 DOI: 10.1093/ofid/ofx024  0.36
2017 Cepeda JA, Thomas DL, Astemborski J, Sulkowski MS, Kirk GD, Mehta SH. Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28329108 DOI: 10.1093/cid/cix207  0.36
2017 Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters MG, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, ... ... Thomas DL, et al. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes and Immunity. PMID 28300059 DOI: 10.1038/gene.2017.2  0.36
2016 Cepeda JA, Solomon SS, Srikrishnan AK, Nandagopal P, Balakrishnan P, Kumar MS, Thomas DL, Sulkowski MS, Mehta SH. Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India. Open Forum Infectious Diseases. 3: ofw156. PMID 27704012 DOI: 10.1093/ofid/ofw156  0.36
2016 Irvin R, McAdams-Mahmoud A, Hickman D, Wilson J, Fenwick W, Chen I, Irvin N, Falade-Nwulia O, Sulkowski M, Chaisson R, Thomas DL, Mehta SH. Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening. Journal of Community Medicine & Health Education. 6. PMID 27525192 DOI: 10.4172/2161-0711.1000431  0.36
2016 Mehta SH, McFall AM, Srikrishnan AK, Kumar MS, Nandagopal P, Cepeda J, Thomas DL, Sulkowski MS, Solomon SS. Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India. Open Forum Infectious Diseases. 3: ofw121. PMID 27419185 DOI: 10.1093/ofid/ofw121  0.36
2016 Mehta SH, Thomas DL. Doing the math on hepatitis C virus treatment. Journal of Hepatology. PMID 27050632 DOI: 10.1016/j.jhep.2016.03.015  0.36
2016 Falade-Nwulia O, Irvin R, McAdams-Mahmoud A, Mehta SH, Niculescu A, Lasola J, Baker D, Eppel A, Chaulk P, Page KR, Sulkowski M, Thomas D. Senior Center-Based Hepatitis C Screening in Baltimore. Open Forum Infectious Diseases. 3: ofv217. PMID 26885546 DOI: 10.1093/ofid/ofv217  0.36
2016 Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Saravanan S, Balakrishnan P, Solomon S, Thomas DL, Sulkowski MS, Mehta SH. Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India. Plos One. 11: e0147879. PMID 26812065 DOI: 10.1371/journal.pone.0147879  0.36
2016 Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. Hepatitis C IgG antibody avidity as a biomarker to estimate population-level incidence. The Journal of Infectious Diseases. PMID 26768250 DOI: 10.1093/infdis/jiw005  0.36
2016 Falade-Nwulia O, Mehta SH, Lasola J, Latkin C, Niculescu A, O'Connor C, Chaulk P, Ghanem K, Page KR, Sulkowski MS, Thomas DL. Public health clinic-based hepatitis C testing and linkage to care in baltimore Journal of Viral Hepatitis. DOI: 10.1111/jvh.12507  0.36
2015 Bailey JR, Dowd KA, Snider AE, Osburn WO, Mehta SH, Kirk GD, Thomas DL, Ray SC. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus. The Journal of Infectious Diseases. PMID 25754978 DOI: 10.1093/infdis/jiv139  0.36
2014 Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters MG, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent. Genes and Immunity. 15: 241-6. PMID 24622687 DOI: 10.1038/gene.2014.11  0.36
2014 Konerman MA, Mehta SH, Sutcliffe CG, Vu T, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology (Baltimore, Md.). 59: 767-75. PMID 24436062 DOI: 10.1002/hep.26741  0.36
2014 Wojcik G, Latanich R, Mosbruger T, Astemborski J, Kirk GD, Mehta SH, Goedert JJ, Kim AY, Seaberg EC, Busch M, Thomas DL, Duggal P, Thio CL. Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. The Journal of Infectious Diseases. 209: 355-9. PMID 23964107 DOI: 10.1093/infdis/jit444  0.36
2014 Fischer WA, Drummond MB, Merlo CA, Thomas DL, Brown R, Mehta SH, Wise RA, Kirk GD. Hepatitis C virus infection is not an independent risk factor for obstructive lung disease. Copd. 11: 10-6. PMID 23862666 DOI: 10.3109/15412555.2013.800854  0.36
2013 Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, Razavi H, Castera L, Poynard T, Muir A, Mehta SH, Dee L, Graham C, Church DR, Talal AH, et al. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Journal of Viral Hepatitis. 20: 745-60. PMID 24168254 DOI: 10.1111/jvh.12173  0.36
2013 Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study. Annals of Internal Medicine. 158: 658-66. PMID 23440167 DOI: 10.7326/0003-4819-158-9-201305070-00604  0.36
2013 Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, ... ... Thomas DL, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Annals of Internal Medicine. 158: 235-45. PMID 23420232 DOI: 10.7326/0003-4819-158-4-201302190-00003  0.36
2013 El-Maouche D, Mehta SH, Sutcliffe CG, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antiviral Therapy. 18: 237-42. PMID 22910231 DOI: 10.3851/IMP2264  0.36
2012 Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. Jama. 308: 370-8. PMID 22820790 DOI: 10.1001/jama.2012.7844  0.36
2012 Claassen CW, Diener-West M, Mehta SH, Thomas DL, Kirk GD. Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1806-13. PMID 22460963 DOI: 10.1093/cid/cis294  0.36
2012 Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, Thomas DL. Stability of liver fibrosis among HCV-infected injection drug users. Antiviral Therapy. 17: 813-21. PMID 22418880 DOI: 10.3851/IMP2085  0.36
2012 Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology (Baltimore, Md.). 56: 544-54. PMID 22331678 DOI: 10.1002/hep.25655  0.36
2011 Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A. Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis. Plos One. 6: e20104. PMID 21637766 DOI: 10.1371/journal.pone.0020104  0.36
2011 El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. Journal of Hepatology. 55: 770-6. PMID 21338640 DOI: 10.1016/j.jhep.2011.01.035  0.36
2011 Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Changes in blood-borne infection risk among injection drug users. The Journal of Infectious Diseases. 203: 587-94. PMID 21282191 DOI: 10.1093/infdis/jiq112  0.36
2011 Woreta TA, Sutcliffe CG, Mehta SH, Brown TT, Higgins Y, Thomas DL, Torbenson MS, Moore RD, Sulkowski MS. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology. 140: 809-17. PMID 21134375 DOI: 10.1053/j.gastro.2010.11.052  0.36
2010 Brown TT, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. Aids (London, England). 24: 811-7. PMID 20186036 DOI: 10.1097/QAD.0b013e3283333651  0.36
2009 Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. Aids (London, England). 23: 2397-404. PMID 19773633 DOI: 10.1097/QAD.0b013e3283324344  0.36
2009 Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore RD, Afdhal N, Torbenson M, Sulkowski M, Thomas DL. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 963-72. PMID 19236273 DOI: 10.1086/597350  0.36
2009 Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. Journal of Hepatology. 50: 36-41. PMID 19012989 DOI: 10.1016/j.jhep.2008.07.039  0.36
2008 Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 135: 226-33. PMID 18457674 DOI: 10.1053/j.gastro.2008.03.022  0.36
2007 Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. Aids (London, England). 21: 2209-16. PMID 18090048 DOI: 10.1097/QAD.0b013e3282f10de9  0.36
2007 Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. Journal of Virology. 81: 6513-22. PMID 17329332 DOI: 10.1128/JVI.02276-06  0.36
2006 Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. Aids (London, England). 20: 2361-9. PMID 17117023 DOI: 10.1097/QAD.0b013e32801086da  0.36
2005 Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users Aids. 19. PMID 16251816 DOI: 10.1097/01.aids.0000192088.72055.90  0.36
2005 Mehta SH, Netski D, Sulkowski MS, Strathdee SA, Vlahov D, Thomas DL. Liver enzyme values in injection drug users with chronic hepatitis C Digestive and Liver Disease. 37: 674-680. PMID 15951255 DOI: 10.1016/j.dld.2005.03.009  0.36
2005 Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. Journal of Hepatology. 43: 78-84. PMID 15894397 DOI: 10.1016/j.jhep.2005.02.025  0.36
2005 Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. Aids (London, England). 19: 585-92. PMID 15802977 DOI: 10.1097/01.aids.0000163935.99401.25  0.36
2005 Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology (Baltimore, Md.). 41: 123-31. PMID 15619237 DOI: 10.1002/hep.20541  0.36
2004 Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. Aids (London, England). 18: 2277-84. PMID 15577540 DOI: 10.1097/00002030-200411190-00008  0.36
2003 Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 577-84. PMID 12902801 DOI: 10.1097/00126334-200308150-00005  0.36
2003 Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL. Hepatitis C virus infection and incident type 2 diabetes Hepatology. 38: 50-56. PMID 12829986 DOI: 10.1053/jhep.2003.50291  0.36
2002 Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. Jama. 288: 199-206. PMID 12095384 DOI: 10.1001/JAMA.288.2.199  0.36
2002 Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections Hepatology. 35: 182-189. PMID 11786975 DOI: 10.1053/jhep.2002.30319  0.36
2001 Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States [1] Hepatology. 33: 1554. PMID 11391549 DOI: 10.1053/jhep.2001.0103306le01  0.36
1993 Thomas DA, Anton F, Kenshalo DR, Williams GM, Dubner R. Noradrenergic and opioid systems interact to alter the detection of noxious thermal stimuli and facial scratching in monkeys. Pain. 55: 63-70. PMID 7904058 DOI: 10.1016/0304-3959(93)90185-R  0.8
1992 Thomas DA, Oliveras JL, Maixner W, Dubner R. Systemic morphine administration attenuates the perceived intensity of noxious heat in the monkey. Pain. 49: 129-35. PMID 1594274 DOI: 10.1016/0304-3959(92)90199-L  0.8
Show low-probability matches.